Alessandro Mandurino-Mirizzi

Dr. Alessandro Mandurino-Mirizzi

Policlinico San Matteo Fondazione, Pavia, Italy
orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 April 2022 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
Alessandro Mandurino-MirizziAlessandro Mandurino-Mirizzi
Alessandro Mandurino-Mirizzi
AMAndrea Munafo
Andrea Munafo
GCGabriele Crimi
Gabriele Crimi
Contrast-associated acute kidney injury (CA-AKI) is an impairment of renal function, which occurs within days of intravascular administration of iodinated contrast media. Taking into account that minimally invasive cardiac interventions are becoming increasingly popular, compared to traditional surgery, given their impact on prognosis and costs, CA-AKI remains a subject of increasing interest for patients and physicians. This review summarizes the epidemiology and risk stratification, diagnostic criteria, pathophysiology and clinical implications of CA-AKI, providing evidence for the most studied preventive strategies.

22 January 2019 in Journal of the American Heart Association
Verified
Journal Article
Open access
GCGabriele Crimi
Gabriele Crimi
NMNuccia Morici
Nuccia Morici
MFMaurizio Ferrario
Maurizio Ferrario
LFLuca A. Ferri
Luca A. Ferri
LPLuigi Piatti
Luigi Piatti
SSStefano De Servi
Stefano De Servi
Background: Elderly patients have high ischemic and bleeding rates after acute coronary syndrome; however, the occurrence of these complications over time has never been studied. This study sought to characterize average daily ischemic rates ( ADIRs ) and average daily bleeding rates ( ADBRs ) over 1 year in patients aged >74 years with acute coronary syndrome undergoing percutaneous coronary intervention who were randomized in the Elderly ACS 2 trial, comparing low‐dose prasugrel (5 mg daily) with clopidogrel (75 mg daily). Methods and Results: ADIRs and ADBRs were calculated as the total number of events, including recurrent events, divided by the number of patient‐days of follow‐up and assessed within different clinical phases: acute (0–3 days), subacute (4–30 days), and late (31–365 days). Generalized estimating equations were used to test the least squares mean differences for the pairwise comparisons of ADIRs and ADBRs and the pairwise comparison of clopidogrel versus prasugrel effects. Globally, ADIRs were 2.6 times (95% CI, 2.4–2.9) higher than ADBRs . ADIRs were significantly higher in the clopidogrel arm than in the low‐dose prasugrel arm in the subacute phase ( P adj <0.001) without a difference in ADBRs ( P adj =0.35). In the late phase, ADIRs remained significantly higher with clopidogrel ( P adj <0.001), whereas ADBRs were significantly higher with low‐dose prasugrel ( P adj <0.001). Conclusions: Ischemic burden was greater than bleeding burden in all clinical phases of 1‐year follow‐up of elderly patients with acute coronary syndrome treated with percutaneous coronary intervention. Low‐dose prasugrel reduced ischemic events in the subacute and chronic phases compared with clopidogrel, whereas bleeding burden was lower with clopidogrel in the late phase. Clinical Trial Registration: URL : http://www.clinicaltrials.gov . Unique identifier: NCT 01777503.

1 October 2021 in The American Journal of Cardiology
Verified
Journal Article
Open access
XWXu Wang
Xu Wang
JMJose M Montero-Cabezas
Jose M Montero-Cabezas
Alessandro Mandurino-MirizziAlessandro Mandurino-Mirizzi
Alessandro Mandurino-Mirizzi
KHKensuke Hirasawa
Kensuke Hirasawa
NMNina Ajmone Marsan
Nina Ajmone Marsan
VDVictoria Delgado
Victoria Delgado
Coronary artery ectasia (CAE) is described in 5% of patients undergoing coronary angiography. Previous studies have shown controversial results regarding the prognostic impact of CAE. The prevalence and prognostic value of CAE in patients with acute myocardial infarction (AMI) remain unknown. In 4788 patients presenting with AMI referred for coronary angiography the presence of CAE (defined as dilation of a coronary segment with a diameter ≥1.5 times of the adjacent normal segment) was confirmed in 174 (3.6%) patients (age 62 ± 12 years; 81% male), and was present in the culprit vessel in 79.9%. Multivessel CAE was frequent (67%). CAE patients were more frequently male, had high thrombus burden and were treated more often with thrombectomy and less often was stent implantation. Markis I was the most frequent angiographic phenotype (43%). During a median follow-up of 4 years (1-7), 1243 patients (26%) experienced a major adverse cardiovascular event (MACE): 282 (6%) died from a cardiac cause, 358 (8%) had a myocardial infarction, 945 (20%) underwent coronary revascularization and 58 (1%) presented with a stroke. Patients with CAE showed higher rates of MACE as compared to those without CAE (36.8% versus 25.6%; p <0.001). On multivariable analysis, CAE was associated with MACE (HR 1.597; 95% CI 1.238-2.060; p <0.001) after adjusting for risk factors, type of AMI and number of narrowed coronary arteries. In conclusion, the prevalence of CAE in patients presenting with AMI is relatively low but was independently associated with an increased risk of MACE at follow-up.

1 December 2020 in European Journal of Preventive Cardiology
Verified
Journal Article
Closed access
PDF file
Alberto SomaschiniAlberto Somaschini
Alberto Somaschini
stefano cornarastefano cornara
stefano cornara
ADAndrea Demarchi
Andrea Demarchi
Alessandro Mandurino-MirizziAlessandro Mandurino-Mirizzi
Alessandro Mandurino-Mirizzi
FFFederico Fortuni
Federico Fortuni
GFGaetano M De Ferrari
Gaetano M De Ferrari

1 February 2021 in Nutrition, Metabolism and Cardiovascular Diseases
Verified
Journal Article
Closed access
Alessandro Mandurino-MirizziAlessandro Mandurino-Mirizzi
Alessandro Mandurino-Mirizzi
SCStefano Cornara
Stefano Cornara
ASAlberto Somaschini
Alberto Somaschini
ADAndrea Demarchi
Andrea Demarchi
MGMarco Galazzi
Marco Galazzi
GFGaetano M. De Ferrari
Gaetano M. De Ferrari

1 June 2020 in Canadian Journal of Cardiology
Verified
Journal Article
Closed access
GCGabriele Crimi
Gabriele Crimi
Alessandro Mandurino-MirizziAlessandro Mandurino-Mirizzi
Alessandro Mandurino-Mirizzi
VGValeria Gritti
Valeria Gritti
VSValeria Scotti
Valeria Scotti
CSClara Strozzi
Clara Strozzi
CKCatherine Marie Klersy
Catherine Marie Klersy